Search Results 111-120 of 16267 for monoclonal antibody
These previous treatments include a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody. This medicine is available only ...
Ixekizumab is a recombinant high-affinity fully human monoclonal antibody that targets IL-17A Immunoglobulin gamma-1 (IgG1)/kappa-class. The purpose of this ...
"Using plasma or human antibodies to treat COVID-19 is an important strategy. ... There are also laboratory methods by which you can make a monoclonal antibody, ...
... Monoclonal Antibody Screening Score. Mayo Clin Proc Innov Qual Outcomes. 2023 Apr; 7 (2):109-121 Epub 2023 Jan 11. View PubMed; MacArthur TA, Goswami J ...
Daratumumab is a drug that is a monoclonal antibody that is directed towards a protein on the myeloma cell. The proposed belantamab-mafodotin combinations ...
... monoclonal antibody) in subjects with relapsed or refractory Multiple Myeloma. Participation eligibility. Participant eligibility includes age, gender, type ...
Of those monoclonal antibody infusions, 16,000 were administered in the Midwest, including 10,000 in rural communities throughout southern Minnesota and western ...
... monoclonal antibody, a proteasome inhibitor, and an immunomodulatory agent) that did not work well. This medicine is available only under a restricted ...
... Monoclonal Antibody Screening Score. Mayo Clin Proc Innov Qual Outcomes. 2023 Apr; 7 (2):109-121 Epub 2023 Jan 11. View PubMed; Wert K, Donaldson AM, Dinh TA ...
... monoclonal antibody therapy in solid organ transplant recipients. J Med Virol. 2023 Jun; 95 (6):e28885. View PubMed; Ordaya EE, Higgins EM, Vergidis P ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Their crucial work saves lives every day. Let Mayo Clinic researchers know they’re appreciated with a quick message.